I for one am not making excesses for how Steve does things

New Post Public Reply Private Reply Replies (0) Message Board
toodles moneystockplayer #21528
241
I for one am not making excesses for how Steve does things if he's quite everyone is mad if he releases what he is able to everyone is in doubt, myself I haven't sold any shares and have been here for over 2 years, have added more.

My decision not to sell was based on the products and Steve's ability as a Salesman, he has a smaller time frame now IMO to get these products out as technology changes fast, we have the best products on the Market at this time.

The new car seat App IMO will be big , car seat manufactures would love to put this right in the seat from get go, with it think how many young lives could be saved.

The Beta testing was completed some time ago but we haven't heard anything about what is going on with it, this puts thoughts in my head that there could be a buyout for this one App just guessing on my part.

The Alcohol App Beta testing has been done for sometime also this is one that could be a life saver also and easily put into cars/truck Big Rigs also, we haven't heard much from him on it so it lets me to believe it could be a buyout possibility.

But what do I know I'm just a investor as everyone else, but I'm not very upset at all with the way things are going at this time and will not sell a share yet.

GO STEVE:

On4 Communications (ONCI) Stock Research Links

ONCI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Caldolor®: A Breakthrough in Opioid-Sparing Pain Relief for Seniors

Updated Category News Views 183

Revolutionizing Pain Management for Older Adults This comprehensive analysis reveals groundbreaking findings about Caldolor® (intravenous ibuprofen) and its effectiveness in managing pain for older adults. As the population ages, the need for safer alternatives for pain relief has significantly increased. Recent studies showcase a marked reduction in opioid consumption...

Continue Reading
Certara Stock Faces Challenges as it Hits a 52-Week Low

Updated Category News Views 120

Certara's Stock Market Performance Certara Inc. (NASDAQ: CERT), recognized as a frontrunner in biosimulation technology, has recently seen its stock price fall to a concerning 52-week low of $10.35. This price decline highlights a notable shift from its previous valuation, indicating a tumultuous time for shareholders. Over the last year, Certara's stock has experienced a...

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 159

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Nebraska Medicine Enhances Cancer Services with Expansion

Updated Category News Views 82

Nebraska Medicine Strengthens Cancer Care Network Nebraska Medicine is making significant strides in enhancing cancer care with the introduction of its new facility, Nebraska Medicine Fred & Pamela Buffett Cancer Center – Kearney. This expansion aims to serve communities across various regions, and it heralds an exciting phase for cancer treatment and research in the...

Continue Reading
Sunshine Silver's IPO: A Spotlight on Silver's Future

Updated Category News Views 8

Sunshine Silver Steps into the Spotlight Ah, the thrill of a fresh IPO. Sunshine Silver Mining & Refining Company, rolling under the ticker SSMR, has announced its initial public offering price—$13.50 a share, with 20 million shares up for grabs. This development has sure piqued the interest of traders eyeing some silver lining. The Figures That Matter Alright, let’s...

Continue Reading